Stock Rich List
Nasdaq: ALLO

Allogene Therapeutics insiders

The officers, directors and 10% owners of Allogene Therapeutics, Inc. who hold the most stock, valued at the live ALLO price.

$0.67
ALLO today −$29K (−4.17%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
3
Their ALLO stock
$9.9M
Market value
$249M
Held by ranked insiders
3.97%

Insiders by value of ALLO holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Arie BelldegrunDirector7,486,803$5.0M2.00%5599th
2David D. ChangPresident and CEO7,207,751$4.8M1.93%14617th
3Vicki L. SatoDirector162,575$108K<0.1%7844th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Allogene Therapeutics; see each profile for the filing.